The store will not work correctly when cookies are disabled.
N-benzyl-N-methyl-2-(1-methyl-4,10-dihydrobenzo[b]pyrazolo[3,4-e][1,4]diazepin-5(1H)-yl)acetamide
ID: ALA4758934
PubChem CID: 162658829
Max Phase: Preclinical
Molecular Formula: C21H23N5O
Molecular Weight: 361.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CN(Cc1ccccc1)C(=O)CN1Cc2cnn(C)c2Nc2ccccc21
Standard InChI: InChI=1S/C21H23N5O/c1-24(13-16-8-4-3-5-9-16)20(27)15-26-14-17-12-22-25(2)21(17)23-18-10-6-7-11-19(18)26/h3-12,23H,13-15H2,1-2H3
Standard InChI Key: YAJWUHBXVCPFLO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
6.8401 -24.8584 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6699 -24.8012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3711 -26.6384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6247 -26.3291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3706 -25.5657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5840 -25.4052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0506 -26.0074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3094 -26.7726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0954 -26.9294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2180 -25.4162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0645 -26.2622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8217 -26.6698 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4433 -26.0755 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0702 -25.3010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9324 -27.4880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4251 -24.1447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8356 -23.4283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4205 -22.7146 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6613 -23.4257 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8311 -21.9982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5948 -22.7172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4160 -21.2845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8315 -20.5699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4171 -19.8566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5906 -19.8588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1802 -20.5801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5970 -21.2904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 5 1 0
1 2 1 0
11 3 1 0
3 4 1 0
2 10 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 10 1 0
12 15 1 0
1 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
18 21 1 0
20 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 361.45 | Molecular Weight (Monoisotopic): 361.1903 | AlogP: 3.14 | #Rotatable Bonds: 4 |
Polar Surface Area: 53.40 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.24 | CX Basic pKa: 3.01 | CX LogP: 2.63 | CX LogD: 2.63 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.78 | Np Likeness Score: -1.58 |
References
1. Sokias R,Werry EL,Alison Cheng HW,Lloyd JH,Sohler G,Danon JJ,Montgomery AP,Du JJ,Gao Q,Hibbs DE,Ittner LM,Reekie TA,Kassiou M. (2020) Tricyclic heterocycles display diverse sensitivity to the A147T TSPO polymorphism., 207 [PMID:32920427] [10.1016/j.ejmech.2020.112725] |